1. Insight into Cisplatin-Resistance Signaling of W1 Ovarian Cancer Cells Emerges mTOR and HSP27 as Targets for Sensitization Strategies
    Kathleen Wantoch von Rekowski et al, 2020, International Journal of Molecular Sciences CrossRef
  2. Exploiting Nanocarriers for Combination Cancer Therapy
    Yi Wen Kong et al, 2016, Intracellular Delivery III CrossRef
  3. Metabolomic analysis of uterine serous carcinoma with acquired resistance to paclitaxel
    Manabu Seino et al, 2018, Oncotarget CrossRef
  4. Aberrant expression of JNK-associated leucine-zipper protein, JLP, promotes accelerated growth of ovarian cancer
    Ji Hee Ha et al, 2016, Oncotarget CrossRef
  5. Delayed Sequential Co-Delivery of Gefitinib and Doxorubicin for Targeted Combination Chemotherapy
    Zilan Zhou et al, 2017, Molecular Pharmaceutics CrossRef
  6. The Jun N-terminal kinases signaling pathway plays a “seesaw” role in ovarian carcinoma: a molecular aspect
    Yingyu Dou et al, 2019, Journal of Ovarian Research CrossRef
  7. Platinum-Based Combination Therapy: Molecular Rationale, Current Clinical Uses, and Future Perspectives
    Chunqiu Yu et al, 2020, Journal of Medicinal Chemistry CrossRef
  8. Targeting MAPK Signaling in Cancer: Mechanisms of Drug Resistance and Sensitivity
    Shannon Lee et al, 2020, International Journal of Molecular Sciences CrossRef
  9. Inhibition of c-Jun N-terminal kinase signaling promotes osteoblastic differentiation of periodontal ligament stem cells and induces regeneration of periodontal tissues
    Hiroshi Kaneko et al, 2021, Archives of Oral Biology CrossRef
  10. Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer
    Yi‐Nan Liu et al, 2019, International Journal of Cancer CrossRef
  11. Antitumor activity of gemcitabine against high-grade meningioma in vitro and in vivo
    Hiroyuki Takeda et al, 2017, Oncotarget CrossRef
  12. The role of endolysosomal trafficking in anticancer drug resistance
    Noor A. Hussein et al, 2021, Drug Resistance Updates CrossRef